JoAnn V. Pinkerton, MD, a “UVA School of Medicine professor of obstetrics and gynecology, wrote an editorial for the journal Menopause entitled “Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer.” The article was published on the journal’s website on August 24, 2022, ahead of print in Volume 29, Issue 9.
In the article, Dr. Pinkerton reviews congruent findings in a large Women’s Health Initiative (WHI) trial of estrogen alone (ET) and smaller randomized controlled trials (RCTS), making a strong case that when prescribed to women after hysterectomy, menopausal ET does not elevate the risk of invasive breast cancer.